HurimBiocel succeeded in animal study on cerebral infarction
Published: 2005-12-02 06:57:00
Updated: 2005-12-02 06:57:00
Hurim Biocel announced in "49th Fall Scientific Conference" of the Korea Society of Infertility at Yonsei Univ. College of Medicine on Nov. 25 that the company had succeeded in the animal study on the cerebral infarction using adult stem cells.
HurimBiocel reported the study results, covering ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
